Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer
JNCI Journal of the National Cancer Institute (2006) - Comments
pubmed: 17077358  doi: 10.1093/jnci/djj414  issn: 1460-2105  issn: 0027-8874 

Charles N. Landen, Chunhua Lu, Liz Y. Han, Karen T. Coffman, Elizabeth Bruckheimer, Jyotsnabaran Halder, Lingegowda S. Mangala, William M. Merritt, Yvonne G. Lin, Changhou Gao, Rosemarie Schmandt, Aparna A. Kamat, Yang Li, Premal Thaker, David M. Gershenson, Nila U. Parikh, Gary E. Gallick, Michael S. Kinch, Anil K. Sood